ロード中...
Payers’ Costly Battle Against Cancer
In a classic managed care struggle between cost containment and physician autonomy, health plans’ efforts to rein in the expense of biotech cancer drugs are meeting stiff resistance from oncologists. They staunchly defend their practice of buying such drugs and marking up their prices to cover servi...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioCommunications LLC
2005
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3564348/ https://ncbi.nlm.nih.gov/pubmed/23393459 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|